Hashimoto's is an autoimmune condition affecting the thyroid gland (ICD-10 E06.3), in which the immune system attacks thyroid tissue, gradually reducing hormone output. The standard approach is usually limited to TSH and levothyroxine replacement; the md_pereligyn protocol adds metabolic diagnostics and systemic correction.